Table 2 Current clinical trials to assess NTZ for treatment of COVID-19
From: Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
COVID-19-related clinical trials | Country | Status |
|---|---|---|
NTZ with ivermectin vs ivermectin with chloroquine | Egypt | Recruiting |
NTZ for moderate case hospitalized patients | Brazil | Recruiting |
NTZ for post-exposure prophylaxis in healthcare workers vs placebo vs dietary supplement | USA | Recruiting |
NTZ 500 mg oral tablet | Mexico | Recruiting |
NTZ vs hydroxychloroquine | Mexico | Recruiting |
NTZ vs favipiravir vs chloroquine | Egypt | Recruiting |
NTZ vs placebo | Egypt | Recruiting |